STATE OF WISCONSIN INVESTMENT BOARD - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$250,003
-58.2%
57,871
-36.2%
0.00%
-50.0%
Q2 2023$597,647
-3.3%
90,690
-0.4%
0.00%0.0%
Q1 2023$618,236
+57.1%
91,051
+71.0%
0.00%
+100.0%
Q4 2022$393,599
-29.7%
53,261
-6.1%
0.00%
-50.0%
Q3 2022$560,000
-14.0%
56,730
-5.0%
0.00%0.0%
Q2 2022$651,000
-20.5%
59,685
-17.6%
0.00%0.0%
Q1 2022$819,000
-27.9%
72,4000.0%0.00%0.0%
Q4 2021$1,136,000
-8.5%
72,4000.0%0.00%
-33.3%
Q3 2021$1,241,000
-20.3%
72,4000.0%0.00%0.0%
Q2 2021$1,557,000
+43.2%
72,4000.0%0.00%
+50.0%
Q1 2021$1,087,000
+7.8%
72,400
-5.6%
0.00%0.0%
Q4 2020$1,008,000
+21.0%
76,700
-11.0%
0.00%0.0%
Q3 2020$833,000
-18.6%
86,200
-3.6%
0.00%
-33.3%
Q2 2020$1,023,000
+10.8%
89,400
+0.3%
0.00%0.0%
Q1 2020$923,000
-28.0%
89,100
+14.1%
0.00%0.0%
Q4 2019$1,282,000
+23.6%
78,1000.0%0.00%0.0%
Q3 2019$1,037,000
-1.5%
78,100
+4.6%
0.00%0.0%
Q2 2019$1,053,000
-21.7%
74,700
+2.2%
0.00%
-25.0%
Q1 2019$1,345,000
-2.3%
73,100
+38.7%
0.00%0.0%
Q4 2018$1,377,000
+14.8%
52,700
+0.8%
0.00%
+33.3%
Q3 2018$1,200,000
+20.5%
52,3000.0%0.00%0.0%
Q2 2018$996,000
+79.1%
52,300
+58.5%
0.00%
+50.0%
Q1 2018$556,000
+10.8%
33,0000.0%0.00%
+100.0%
Q4 2017$502,000
-15.1%
33,0000.0%0.00%
-50.0%
Q3 2017$591,000
+9.9%
33,0000.0%0.00%0.0%
Q2 2017$538,00033,0000.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Profit Investment Management, LLC 326,997$1,412,6271.00%
Stonepine Capital Management, LLC 477,903$2,064,5410.69%
Krensavage Asset Management, LLC 360,429$1,5570.57%
Nantahala Capital Management 1,000,000$4,320,0000.37%
Monaco Asset Management SAM 135,000$583,2000.17%
CTC Alternative Strategies, Ltd. 18,400$79,4880.15%
GSA CAPITAL PARTNERS LLP 406,019$1,7540.15%
Sio Capital Management, LLC 97,616$421,7010.13%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$673,9200.13%
Virtus ETF Advisers LLC 48,530$209,6500.13%
View complete list of VANDA PHARMACEUTICALS INC shareholders